Hemostemix Files for Ethics Approval of its Study of Vascular Dementia

Read More

Hemostemix’s Insider Lead Order of $330,000 Private Placement

Read More

Hemostemix Files FDA Submission for Basket Protocol (Filing 1517) to Advance ACP-01 (VesCell™) Across Multiple Ischemic and Vascular Indications Simultaneously

Read More

Hemostemix to Present its Clinical Data of the Treatment of Severe Angina

Read More

Hemostemix to Present at Life Science Investor Forum

Read More

Hemostemix Announces TSXV Approval of Debt Settlement at $0.20 per Share

Read More

Hemostemix Announces Private Placement

Read More

Hemostemix (PreCerv Inc.) Retains Chris McNorgan PhD to License NCP-01 to Neural Electrode Brain Implant Company

Read More

Hemostemix’ “Your Fountain of Youth” Trademark Granted by Japan Patent Office

Read More

Hemostemix Announces Engagement of Oak Hill Asset Management Inc.

Read More